Brain metastases occur when cancer cells spread from their original site to the brain. Any cancer can spread to the brain, but the types most likely to cause brain metastases are lung, breast, colon, kidney and melanoma.
Brain metastases, or secondary brain tumors, occur in 10 to 30 percent of adults with cancer. As the metastatic brain tumors grow, they create pressure on and change the function of surrounding brain tissue. Brain metastases can cause many signs and symptoms.
Treatment for people whose cancer has spread to the brain is often surgery, radiation therapy or both. In some cases, chemotherapy and immunotherapy are helpful. Treatment is often focused on reducing pain and symptoms resulting from the cancer.
Brain metastases care at Mayo Clinic
Brain tumor symptoms vary depending on the tumors' size, number, location and rate of growth.
Signs and symptoms of brain metastases include:
- Headache, sometimes with vomiting or nausea
- Mental changes, such as increasing memory problems
When to see a doctor
Make an appointment with your doctor if you have persistent signs and symptoms that concern you. If you've been treated for cancer in the past, tell your doctor about your medical history.
Brain metastases occur when cancer cells travel through the bloodstream or the lymph system from the original tumor and spread (metastasize) to the brain. There they begin to multiply. Metastatic cancer that spreads from its original location is known by the name of the primary cancer. For example, cancer that has spread from the breast to the brain is called metastatic breast cancer, not brain cancer.
There are many theories about what causes some cancers to spread and why some cancers travel to the brain. Brain metastases from lung cancer are often found early in the course of the disease, and those from breast cancer develop late.
Any type of cancer can spread to the brain, but having one of the following types of cancer puts you at increased risk of brain metastases:
- Lung cancer
- Breast cancer
- Colon cancer
- Kidney cancer
Brain metastases care at Mayo Clinic
March 03, 2018
- McWilliams RR, et al. Treatment of brain metastases from melanoma. Mayo Clinic Proceedings. 2003;78:1529.
- Mikkelsen T, et al. The role of prophylactic anticonvulsants in the management of brain metastases: A systematic review and evidence-based clinical practice guidelines. Journal of Neuro-Oncology. 2010;96:97.
- Linskey ME, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology. 2010;96:45.
- Gaspar LE, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guidelines. Journal of Neuro-Oncology. 2010;96:17.
- AskMayoExpert. Brain metastases. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
- Rades D, et al. Predictors of survival in patients with brain metastases from gastric cancer. Neoplasma. 2017;64:136.
- Brown PD, et al. Effect of radiosurgery alone vs. radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial. JAMA. 2016;316:401.
- Rades D, et al. Prognostic factors after whole-brain radiotherapy alone for brain metastases from malignant melanoma. Anticancer Research. 2016;36:6637.
- Crozier JA, et al. Breast cancer brain metastases: Molecular subtype, treatment and survival. Breast Disease. 2016;36:133.
- Brown PD, et al. NCCTG N0574 (alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases. Journal of Clinical Oncology. 2015;33(suppl 18):LBA4.
- Loeffler JS. Overview of the treatment of brain metastases. https://www.uptodate.com/home. Accessed April 18, 2017.
- Loeffler JS. Epidemiology, clinical manifestations, and diagnosis of brain metastases. https://www.uptodate.com/home. Accessed April 18, 2017.
- Metastatic cancer. National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/Sites-Types/metastatic. Accessed April 18, 2017.
- Walsh D, et al. Brain metastases. In: Palliative Medicine. Philadelphia, Pa.: Saunders Elsevier; 2009. https://www.clinicalkey.com. Accessed April 18, 2017.
- Winn HR. Metastatic brain tumors. In: Youmans and Winn Neurological Surgery. 7th ed. Philadelphia, Pa.: Elsevier; 2017. https://www.clinicalkey.com. Accessed April 18, 2017.
- Heim JB, et al. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix. Proceedings of the National Academy of Sciences of the United States. 2017;114:3933.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. March 8, 2017.
- Le Rhun E, et al. Leptomeningeal metastases of solid cancer. Current Opinions in Neurology. 2016;29:797.
- Rades D, et al. A new scoring tool to assess overall survival in patients with intracerebral metastases from gynecological cancers. International Journal of Gynecologic Cancer. 2017;27:597.
- Rades D, et al. A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients with irradiated for up to three brain metastases. BMC Cancer. 2017;17:30.
- Cheville AL, et al. Nested cohort study to identify characteristics that predict near-term disablement from lung cancer brain metastases. Archives of Physical Medicine and Rehabilitation. 2017;98:303.
- Klos KJ, et al. Brain metastases. The Neurologist. 2004;10:31.
- O'Neill BP, et al. Brain metastatic lesions. Mayo Clinic Proceedings. 1994;69:1062.
- Thinking about CAM. National Cancer Institute. https://www.cancer.gov/publications/patient-education/thinking-about-cam. Accessed April 20, 2017.
- Porter AB (expert opinion). Mayo Clinic, Scottsdale, Arizona. May 2, 2017.
- Vargo MM. Brain tumors and metastases. Physical Medicine and Rehabilitation Clinics of North America. 2017;28:115.